Alexander Eremiev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexander Eremiev has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adhith Palla
Department of Neurosurgery, NYU Langone Health, New York, New York, USA
1 shared publication - Caroline Kremer
Department of Neurosurgery, New York University Langone Health, New York, New York, USA
1 shared publication - Daniel N. de Souza
Department of Neurosurgery, New York University Langone Health, New York, New York, USA
1 shared publication - David H. Harter
Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Langone Medical Center, New York, New York, USA
1 shared publication - Eric Alexander Grin
Department of Neurosurgery, New York University Langone Health, New York, New York, USA
1 shared publication - Eric Bao
Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA
1 shared publication
Latest Publications
- 9 July 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Stereotactic Navigation and Intracranial Hemorrhage Risk Following Ventricular Catheter Placement: A Single-Center Cohort Study
BACKGROUND AND OBJECTIVES: Cerebrospinal fluid shunting is a common treatment for hydrocephalus. Several techniques for ventricular catheter placement exist, yet comparative safety data remain limited. This study evaluated whether stereotactic navigation-assisted ventricular catheter placement is associated with reduced 30-day postoperative intracranial hemorrhage (ICH) rates. METHODS: This was a retrospective analysis of adults who underwent frontal or occipital shunt placement for hydrocephalus between 2014 and 2023. The primary exposure variable was the use of stereotactic navigation for ventricular catheter placement. The primary outcomes were hospital length of stay (LOS) and 30-day postoperative ICH. RESULTS: A total of 541 shunt placements were included (median age 72.5 years; 51.6% male). Normal pressure hydrocephalus represented the most common underlying diagnosis (60.3%). Stereotactic navigation was used in 221 cases (40.9%) and was more frequently employed in younger patients (66.0 vs 73.9 years; P < .001), more recent years (median 2021 vs 2019; P < .001), and cases involving non-normal pressure hydrocephalus diagnoses ( P < .001). Overall, 12 patients (2.2%) developed ICH within 30 days of surgery. The 30-day ICH rate was significantly lower with stereotactic navigation (0.5% vs 3.4%; odds ratio 0.13, 95% CI 0.02-1.00; P = .033), corresponding to an absolute risk reduction of 2.99% and a number needed to treat of 34. Kaplan-Meier analysis demonstrated superior hemorrhage-free survival with navigation-assisted placement (log-rank P = .021), with most events occurring within the first 14 days postoperatively. Propensity-matched analysis demonstrated a similar effect size but fell short of statistical significance. Navigation use was not independently associated with LOS or any other complications. CONCLUSION: Stereotactic navigation-assisted ventricular catheter placement was associated with lower rates of 30-day postoperative ICH compared with non-navigation–assisted placement, with a number needed to treat of 34. Given the absence of adverse effects on LOS or overall complication rates, these findings support routine consideration of neuronavigation during shunt placement when available.
- 9 July 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Stereotactic Navigation and Intracranial Hemorrhage Risk Following Ventricular Catheter Placement: A Single-Center Cohort Study
BACKGROUND AND OBJECTIVES: Cerebrospinal fluid shunting is a common treatment for hydrocephalus. Several techniques for ventricular catheter placement exist, yet comparative safety data remain limited. This study evaluated whether stereotactic navigation-assisted ventricular catheter placement is associated with reduced 30-day postoperative intracranial hemorrhage (ICH) rates. METHODS: This was a retrospective analysis of adults who underwent frontal or occipital shunt placement for hydrocephalus between 2014 and 2023. The primary exposure variable was the use of stereotactic navigation for ventricular catheter placement. The primary outcomes were hospital length of stay (LOS) and 30-day postoperative ICH. RESULTS: A total of 541 shunt placements were included (median age 72.5 years; 51.6% male). Normal pressure hydrocephalus represented the most common underlying diagnosis (60.3%). Stereotactic navigation was used in 221 cases (40.9%) and was more frequently employed in younger patients (66.0 vs 73.9 years; P < .001), more recent years (median 2021 vs 2019; P < .001), and cases involving non-normal pressure hydrocephalus diagnoses ( P < .001). Overall, 12 patients (2.2%) developed ICH within 30 days of surgery. The 30-day ICH rate was significantly lower with stereotactic navigation (0.5% vs 3.4%; odds ratio 0.13, 95% CI 0.02-1.00; P = .033), corresponding to an absolute risk reduction of 2.99% and a number needed to treat of 34. Kaplan-Meier analysis demonstrated superior hemorrhage-free survival with navigation-assisted placement (log-rank P = .021), with most events occurring within the first 14 days postoperatively. Propensity-matched analysis demonstrated a similar effect size but fell short of statistical significance. Navigation use was not independently associated with LOS or any other complications. CONCLUSION: Stereotactic navigation-assisted ventricular catheter placement was associated with lower rates of 30-day postoperative ICH compared with non-navigation–assisted placement, with a number needed to treat of 34. Given the absence of adverse effects on LOS or overall complication rates, these findings support routine consideration of neuronavigation during shunt placement when available.
- 8 February 2022
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 36 (4-6) , 309-326
Development of Hydropersulfide Donors to Study Their Chemical Biology
Significance: Hydropersulfides (RSSH) are ubiquitous in prokaryotes, eukaryotic cells, and mammalian tissues. The unique chemical properties and prevalent nature of these species suggest a crucial role of RSSH in cell regulatory processes, yet little is known about their physiological functions. Recent Advances: Examining the biological roles of RSSH species is challenging because of their inherent instability. In recent years, researchers have developed a number of small-molecule donors that efficiently release RSSH in response to various stimuli, including pH, thiols, reactive oxygen species, enzymes, and light. These RSSH donors have provided researchers with chemical tools to uncover the potential function and role of RSSH as physiological signaling and/or protecting agents. Critical Issues: Because RSSH, hydrogen sulfide (H 2 S), and higher order polysulfides are related to each other and can be present simultaneously in biological systems, distinguishing among the activities due to each of these species is difficult. Discerning this activity is critical to elucidate the chemical biology and physiology of RSSH. Moreover, although RSSH donors have been shown to confer cytoprotection against oxidative and electrophilic stress, their biological targets remain to be elucidated. Future Directions: The development of RSSH donors with optimal drug-like properties and selectivity toward specific tissues/pathologies represents a promising approach. Further investigation of releasing efficiencies in vivo and a clear understanding of RSSH biological responses remain targets for future investigation. Antioxid. Redox Signal . 36, 309–326.
- 8 February 2022
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 36 (4-6) , 309-326
Development of Hydropersulfide Donors to Study Their Chemical Biology
Significance: Hydropersulfides (RSSH) are ubiquitous in prokaryotes, eukaryotic cells, and mammalian tissues. The unique chemical properties and prevalent nature of these species suggest a crucial role of RSSH in cell regulatory processes, yet little is known about their physiological functions. Recent Advances: Examining the biological roles of RSSH species is challenging because of their inherent instability. In recent years, researchers have developed a number of small-molecule donors that efficiently release RSSH in response to various stimuli, including pH, thiols, reactive oxygen species, enzymes, and light. These RSSH donors have provided researchers with chemical tools to uncover the potential function and role of RSSH as physiological signaling and/or protecting agents. Critical Issues: Because RSSH, hydrogen sulfide (H 2 S), and higher order polysulfides are related to each other and can be present simultaneously in biological systems, distinguishing among the activities due to each of these species is difficult. Discerning this activity is critical to elucidate the chemical biology and physiology of RSSH. Moreover, although RSSH donors have been shown to confer cytoprotection against oxidative and electrophilic stress, their biological targets remain to be elucidated. Future Directions: The development of RSSH donors with optimal drug-like properties and selectivity toward specific tissues/pathologies represents a promising approach. Further investigation of releasing efficiencies in vivo and a clear understanding of RSSH biological responses remain targets for future investigation. Antioxid. Redox Signal . 36, 309–326.